Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Carrier Screening Market will be valued at $8.39 billion by 2032 as per a forecast period that exhibits a Compound Annual Growth Rate (CAGR) of 14.4%. Several factors create the dynamic environment for the Carrier Screening Market’s growth and development. Over time, carrier screening has become an integral part of family planning and preconception care as it is genetic testing that detects carriers with a gene mutation linked to a specific genetic disorder. The market dynamics have been driven by increased knowledge about genetic disorders, better genetic test technologies, personalization of medicine.
Carrier Screening Market dynamics are shaped by research and development (R&D). Genetic testing companies and researchers are actively involved in developing new and improving existing screening technologies to increase accuracy, accessibility, and conditions covered. Advances in next-generation sequencing techniques, bioinformatics, and expanded gene panels continue expanding the number of screened conditions influencing the market positively in this way too. Furthermore, improvements in this area change the industry through novel comprehensive options for carrier screening.
Technological progress also makes an important contribution to market dynamics of carrier screening as well. For example, innovations such as whole exome sequencing or whole genome sequencing in relation to sequencing technologies have made carrier screenings wider and deeper too. Additionally better bioinformatics tools for variant interpretation result in more accurate clinically relevant results thus making this decision easier than ever before while making decisions on patients’ care during diagnosis easier not only through enhancing options for examination but also through growing overall demand for advanced tools that health providers could use while addressing them.
Regulatory issues regarding ethical guidelines influence carrier screening’s market dynamic just like any other factor does . Thus strict regulatory standards together with ethical considerations ensure safe application correct implementation while using gene-based diagnostics devices etc. On the other hand when it comes down to creating credibility in markets nothing surpasses adherence to these rules hence organizations do navigate regulatory landscapes strategically preparing way new approaches improved tests which may influence the whole industry dynamics.
Another significant factor impacting market dynamics is competition among genetic testing companies and healthcare stakeholders. To strengthen their market position, companies employ different approaches such as partnerships, collaborations and entering new markets to provide comprehensive carrier screening options. The competitive landscape enhances innovation as firms compete on new improved test offering that includes expanded conditions covered and also improved user experience. Consequently, the growth of this segment has been supported by numerous latest carrier screening technologies targeting different groups of healthcare providers and individuals in order to address these changing needs in the foreseeable future.
Carrier screening’s market dynamics can also be affected by economic factors. This will directly affect patients’ ability to afford or access it due to changes in health spending patterns during economic downturns. Cost-sensitive measures in terms of health services provision like carrier screening can be applied especially during economic recessions while booming economies can lead to increased investment into health care leading to a higher demand for carrier screening services.
Market dynamics are also influenced by consumer tastes and perceptiveness. This has resulted in increased demand for such tests from individuals or couples who have become aware of the necessity of genetic carrier testing in family planning. All these factors can have an impact on market fragmented services to bring it together and create a product that will boost innovation through new methods and improve patient engagement including novel modalities.
Carrier Screening Market Highlights:
Carrier Screening Market Overview
The Career Screening Market size is anticipated to reach USD 8.39 Billion by 2032 at 14.4% CAGR during the forecast period 2023-2032. The carrier screening is genetic testing that is used to under the cause of gene disorders. This type of test is mainly done during the pregnancy and provides significant information about the woman's risks for reproduction and chances of a genetic disorder of the child.
The demand for this type of test has increased to prevent any disorders and risks. With the help of expanded carrier screening, it is now easy to detect around 100 disorders from a single sample. Also, the targeted carrier screening helps in identifying any disease by analyzing the family medical history. Also, medical conditions such as pulmonary and haematological conditions will have the highest growth in the Career Screening Market.
COVID-19 Analysis
The Coronavirus disease caused a huge ruckus in the Career Screening Market. Various incidents like financial disruption, supply, and management, manufacturing units were halted so several months. This led to an increase in the gap in production and demand in the market. Moreover, after the waiver of lockdown, various key players began to improve the market growth with investments, partnerships, acquisitions, etc. Henceforth, the market will observe immense growth in the future years.
Market Dynamics
Market Drivers
The increasing demand for early detection of diseases and development in technology will drive the Career Screening Market Growth. Also, the investment by key players for new technologies will further improve the market growth in the future.
Restraints
The low awareness for new technologies will act as a significant restraint for the Career Screening Market Growth. The unavailability of basic guidelines for carrier screening will further restrict the market growth.
Opportunities
The increasing investments by key players and rapid technological advancements will offer new opportunities for Career Screening Market Growth.
Challenges
The problem regarding the accuracy of data can be a major challenge for the Career Screening Market. Henceforth, this factor can hinder the Career Screening Market.
Cumulative Analysis
The Compound Annual Growth Rate (CAGR) of the Carrier Screening Market is estimated to boost up to 17.40%. It is also evaluated that the Carrier Screening industry Value will further reach up to USD 7.40 Billion by the studied forecast period 2021-2028.
Value Chain Analysis
The improvement in technology and rapid technological development is projected to boost the Carrier Screening Market Trends. Also, the strengthening of the supply chain and rising demand for better healthcare infrastructure will further enhance the value chain of the Carrier Screening industry in the forthcoming years.
Market Segmentations
The Carrier Screening Market Size is segmented into Products and Services, Type, and Medical Condition. Based on type, the Carrier Screening Market is fragmented into Targeted Carrier Screening, Expanded Carrier Screening. The Expanded Carrier Screening is divided into Customized Panel Testing and Predesigned Panel Testing. With the help of expanded carrier screening, it is easy to detect around 100 gene disorders. Furthermore, the targeted carrier screening helps identify gene disorders by analyzing the family history.
Based on Medical conditions, the Carrier Screening Market is bifurcated into Hematological Conditions, Pulmonary Conditions, Neurological Conditions, and others. The hematological sub-segment is anticipated to have the largest share in the market. It is mainly due to the increasing cases of sickle disorders in patients. Also, the pulmonary conditions will have the fastest growth in the Carrier Screening Market. The others sub-segments include diseases like trisomy 13, Marfan syndrome, and Down syndrome.
Based on Product and Services, the Carrier Screening Market is again divided into Product and Service. The services sub-segment is evaluated to grow at the fastest rate. Also, the product sub-segment is predicted to observe high growth with the increasing awareness and early diagnosis facility.
Regional Analysis
On the basis of region, the Carrier Screening Market is divided into North America (U.S, Mexico, and Canada), Europe (Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, Australia, South Korea, and Rest of Asia Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
According to the Carrier Screening Market Forecast by MRFR, it is estimated that North America will hold the largest share in the forthcoming years. The presence of various key players and advanced healthcare solutions are driving the Carrier Screening Market Growth in this region.
Secondly, Europe is predicted to have the second-largest Carrier Screening Market Share in the studied forecast period. With the increasing emphasis on development and research, the market is evaluated to record robust growth. Also, the increasing demand to manufacture personalized machines will influence the Carrier Screening industry positively.
Thirdly, the Asia-Pacific region is predicted to have the fastest growth in the future years. The increasing investments by key players mainly in India and China are playing a crucial role in driving the market. Also, the rising awareness for genetic disorders and the increasing geriatric population are speculated to propel the Carrier Screening Market.
Competitive Landscape
There are various companies present in the Carrier Screening Market. They implement various market strategies to improve their business portfolio across the world. These key players do mergers, partnerships, acquisitions, new ventures, etc. Some of the key players in the Carrier Screening Market are as follows.
- Opko Health (US)
- Quest Diagnostics Incorporated (US)
-
Eurofins Scientific (Luxembourg) - Sema4 (US)
- Fulgenmt Genetics Inc. (US)
- Invitae Corporation (US)
- Laboratory Corporation of America Holdings (US)
-
Illumina Inc. (US) - Natera Inc. (US)
- BGI Group (China)
- deCODE Genetics (Iceland)
- Agilent Technologies (US)
- Genomic Health (US)
- Pathway Genomics (US)
- Bio-Rad Laboratories Inc. (US)
- Admera Health (US)
- Abbott Laboratories (US)
Recent Developments
- GenPath Women's Health which is the subsidiary of OPKO Health in 2017 launched a prenatal screen with a non-invasive procedure called CalriTest. This device will help to identify the abnormal chromosomes.
- Invitae Corporation in 2018 launched its screening device for comprehensive genetic.
Report Overview
The report overview of Carrier Screening Market Outlook is as follows.
- Market Overview
- COVID-19 Analysis
- Dynamics of the Market
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Analysis
- Recent Development
Report Score and Segmentation
The report score is to give information about the Carrier Screening Market Analysis. It highlights information such as market value, CAGR, opportunities, challenges, etc. The information provided in this report is gathered from various primary and secondary sources.
-
Study Period- 2021-2028 -
Base Year-2021 -
Forecast Period- 2021-2028 -
Historical Period-2017-2020
Carrier Screening Market Segmentation
Carrier Screening By Type
- Targeted Carrier Screening
- Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
Carrier Screening By Medical Condition
- Hematological Conditions
- Pulmonary Conditions
- Neurological Conditions
- Others
Carrier Screening By Services and Products
- Products
- Services
Carrier Screening By Region
- North America (U.S, Mexico, and Canada)
- Europe (Germany, France, Spain, Italy, and Rest of Europe)
- Asia Pacific (Japan, India, Australia, South Korea, and Rest of Asia Pacific)
- LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
